Categories AlphaGraphs, Earnings, Health Care
Key highlights from AngioDynamics (ANGO) Q1 2021 earnings results
AngioDynamics Inc. (NASDAQ: ANGO) reported first quarter 2021 earnings results today.
Net sales increased 6.3% to $70.2 million but were impacted by the disruption to procedure volumes due to the COVID-19 pandemic.
The company recorded a net loss of $4.3 million, or $0.11 per share, compared to a net loss of approx. $1.3 million, or $0.03 per share, a year ago. Adjusted net income was $0.6 million, or $0.02 per share.
AngioDynamics expects fiscal year 2021 net sales to be in the range of $278-284 million and adjusted EPS to be $0.00 to $0.05.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
GameStop (GME) Earnings: Q1 loss narrows on 25% sales growth
Video game retailer GameStop Corp. (NYSE: GME), which has become the talk of the town after the unprecedented stock rally in recent weeks, reported a narrower loss for the first
Should you invest in Steel Dynamics (STLD) stock after 78% rally?
The steel industry managed to shrug off the pandemic blues earlier than expected as the recovery in industrial activity pushed up demand. With the vaccination drive and the government’s aggressive
Campbell Soup (CPB) Q3 Earnings: Key financials and quarterly highlights
Campbell Soup Company (NYSE: CPB) reported third-quarter 2021 earnings results today. Net sales decreased 11% year-over-year to $1.98 billion, as a result of lapping the demand surge at the onset
